ProTransit Nanotherapy Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 2
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $494K
Latest Deal Amount
  • Investors
  • 4

ProTransit Nanotherapy General Information


Provider of a proprietary sustained-release nanoparticle delivery system intended to treat conditions with a variety of active ingredients. The company's initial system contains antioxidant enzymes and is for skincare, where the product helps reduce photoaging caused by free radicals following sun exposure with other topical applications including active ingredients for hair loss and plaque psoriasis, enabling under development are nanoparticles for the treatment of traumatic brain injury, hypertension and prevention of skin damage from radiotherapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 16514 L Circle
  • Omaha, NE 68135
  • United States
+1 (608) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ProTransit Nanotherapy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 15-Aug-2018 $494K 00000 Completed Pre-Clinical Trials
2. Grant 08-Mar-2017 00.00 00000 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 21-Nov-2014 $250K $250K Completed Pre-Clinical Trials
To view ProTransit Nanotherapy’s complete valuation and funding history, request access »

ProTransit Nanotherapy Executive Team (2)

Name Title Board Seat Contact Info
Gary Madsen Ph.D Co-Founder, President & Chief Executive Officer
Vinod Labhasetwar Ph.D Co-Founder
To view ProTransit Nanotherapy’s complete executive team members history, request access »

ProTransit Nanotherapy Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProTransit Nanotherapy Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
Artesian Beauty Corporation Minority 000 0000 000000 0
Invest Nebraska Accelerator/Incubator Minority 000 0000 000000 0
To view ProTransit Nanotherapy’s complete investors history, request access »